Skip to main content
OpenTrials
Completed

NCT Number: NCT03973099

Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen

Nelumbinis Semen, has been widely used as treatment of post-menopause symptoms in women for hundreds of years in many Asian countries. This study examines whether PM011, standardized herbal medicine made from Nelumbinis Semen, treats stress in above 5 of BDI score of human subjects and discusses its potential as treatment for depressed patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Nelumbinis Semen, has been widely used as treatment of post-menopause symptoms in women for hundreds of years in many Asian countries. This study examines whether PM011, standardized herbal medicine made from Nelumbinis Semen, treats stress in above 5 of BDI score of human subjects and discusses its potential as treatment for depressed patients. Subjects were divided into three groups, the placebo-treated group (n = 10), the PM011-2.4 g treated group (n = 11) and PM011-4.8 g treated group (n = 11) per day. Alpha/Beta ratio of electroencephalogram (EGG), Beck Depression Inventory (BDI) and Stress Response Inventory (SRI) were conducted in order to measure changes in stress before and after 2 weeks of PM011 treatment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

<Inclusion Criteria>

  • Volunteers were selected based on following meet conditions;Men and women, who have willingness and capacity to comply with the study protocol, are included if they were aged 18 to 65 years.
  • Volunteers, who can understand Korean and English alphabet are selected.
  • Volunteers, who can communicate with clinical trial performer fully, comply with the all tests and medical examinations performed by study protocol.
  • All volunteers or their protectors understand purpose of study fully and sign their names or seal.
  • Volunteers, who do not come under exclusion criteria are selected.
  • BDI score of Volunteers, who can be >= 5.

<Exclusion Criteria>

  • Volunteers were excluded if they are applied to following meet conditions; Volunteers with fasting glucose level over 126 mg/dl.
  • Volunteers with hypertension as having over 140 mmHg of systolic blood pressure or 90 mmHg of diastolic blood pressure.
  • Volunteers with blood thyroid stimulating hormone below 0.3 or over 4.0.
  • Men with hemoglobin below 13.0 g/dl and women with hemoglobin below 12.0 g/dl.
  • Volunteers with abnormality of liver function as having over 1.5 times of normal levels of ALT or AST.
  • Patients with infections in upper airways or chronic diseases.
  • Mental illness patients with such as alcoholism.

Treatment and study plan

PM011

Dietary Supplement

PM011 is a 400 mg hard gelatin capsule containing water extracts of Nelumbinis Semen. The sprayed-dry extract of the herbal medicine used was purchased from Sun Ten pharmaceutical company in Taiwan. Each participant received twelve capsules of PM011, which divided into 2.4 g treatment or 4.8 g treatment group or placebo daily for two weeks and was instructed to take six capsules after breakfast and six capsules after dinner. Subjects in the placebo group received the equivalent amount of starch and lactose mixture capsules and administered with the same schedule.

Other names: Nelumbinis Semen

Primary outcomes

  1. Beck Depression Inventory (BDI)

    Time frame: Change from baseline BDI score at 2 weeks

    BDI is a 21 item, self rated inventory with each item rated with a set of four possible answer choices of increasing intensity.

  2. Stress Response Inventory or Test (SRI or SRT)

    Time frame: Change from baseline SRI or SRT score at 2 weeks

    SRI is highly reliable and valid, and that it is utilized as an effective measure of stress for research in stress-related fields in Korea. SRI is a total of 39 response items under the seven subscales. The seven subscales are divided into tension (A), aggression (B), somatization (C), anger (D), depression (E), fatigue (F), and frustration (G). When the test is scored, a value of 0 to 4 is assigned for each answer and then the total score is compared to a key to determine the stress's severity.

Secondary outcomes

  1. Alpha/beta ratio of electroencephalogram (EEG)

    Time frame: Change from baseline Alpha/beta ratio of electroencephalogram (EEG) at 2 weeks

    Electroencephalogram (EEG) is used to measure the brain waves. Each wave pattern is associated with different mood state and state of consciousness. Alpha is one of four basic brain waves (delta, theta, alpha and beta) which make up the EEG. Alpha is seen in wakefulness where there is relaxed and effortless alertness. Beta is seen in highly stressful situations, and where there is difficult mental concentration and focus. Therefore, high alpha and less beta waves have been used as indices of relaxation, arousal, anti-stress, and better concentration.

Sponsors and collaborators

Lead sponsor

VTBIO Co. LTD

Industry

Registry information

Official study title

Double Blinded, Randomized, Placebo-controlled Clinical Study for Evaluating Anti-stress Effects of Nelumbinis Semen by 2 Week Administration

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Jun 4, 2019
Registry last updated
Jun 4, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.